Extracellular vesicles in liver pathobiology: Small particles with big impact

Petra Hirsova, Samar C Ibrahim, Vikas K. Verma, Leslie A. Morton, Vijay Shah, Nicholas F La Russo, Gregory James Gores, Harmeet M Malhi

Research output: Contribution to journalReview article

51 Citations (Scopus)

Abstract

Extracellular vesicles (EVs) are nanometer-sized, membrane-bound vesicles released by cells into the extracellular milieu. EVs are now recognized to play a critical role in cell-to-cell communication. EVs contain important cargo in the form of proteins, lipids, and nucleic acids and serve as vectors for delivering this cargo from donor to acceptor or target cell. EVs are released under both physiologic and pathologic conditions, including liver diseases, and exert a wide range of effects on target cells. This review provides an overview on EV biogenesis, secretion, cargo, and target cell interactions in the context of select liver diseases. Specifically, the diverse roles of EVs in nonalcoholic steatohepatitis, alcoholic liver disease, viral hepatitis, cholangiopathies, and hepatobiliary malignancies are emphasized. Liver diseases often result in an increased release of EVs and/or in different cargo sorting into these EVs. Either of these alterations can drive disease pathogenesis. Given this fact, EVs represent a potential target for therapeutic intervention in liver disorders. Because altered EV composition may reflect the underlying disease condition, circulating EVs can be exploited for diagnostic and prognostic purposes as a liquid biopsy. Furthermore, ex vivo modified or synthesized EVs can be engineered as therapeutic nano-shuttles. Finally, we highlight areas that merit further investigation relevant to understanding how EVs regulate liver disease pathogenesis. (Hepatology 2016;64:2219-2233).

Original languageEnglish (US)
Pages (from-to)2219-2233
Number of pages15
JournalHepatology
Volume64
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Liver
Liver Diseases
Cell Communication
Extracellular Vesicles
Alcoholic Liver Diseases
Gastroenterology
Nucleic Acids
Hepatitis
Lipids
Biopsy
Membranes
Therapeutics
Neoplasms
Proteins

ASJC Scopus subject areas

  • Hepatology

Cite this

Extracellular vesicles in liver pathobiology : Small particles with big impact. / Hirsova, Petra; Ibrahim, Samar C; Verma, Vikas K.; Morton, Leslie A.; Shah, Vijay; La Russo, Nicholas F; Gores, Gregory James; Malhi, Harmeet M.

In: Hepatology, Vol. 64, No. 6, 01.12.2016, p. 2219-2233.

Research output: Contribution to journalReview article

@article{5848f1799bc9471da60fcc9e13cc3786,
title = "Extracellular vesicles in liver pathobiology: Small particles with big impact",
abstract = "Extracellular vesicles (EVs) are nanometer-sized, membrane-bound vesicles released by cells into the extracellular milieu. EVs are now recognized to play a critical role in cell-to-cell communication. EVs contain important cargo in the form of proteins, lipids, and nucleic acids and serve as vectors for delivering this cargo from donor to acceptor or target cell. EVs are released under both physiologic and pathologic conditions, including liver diseases, and exert a wide range of effects on target cells. This review provides an overview on EV biogenesis, secretion, cargo, and target cell interactions in the context of select liver diseases. Specifically, the diverse roles of EVs in nonalcoholic steatohepatitis, alcoholic liver disease, viral hepatitis, cholangiopathies, and hepatobiliary malignancies are emphasized. Liver diseases often result in an increased release of EVs and/or in different cargo sorting into these EVs. Either of these alterations can drive disease pathogenesis. Given this fact, EVs represent a potential target for therapeutic intervention in liver disorders. Because altered EV composition may reflect the underlying disease condition, circulating EVs can be exploited for diagnostic and prognostic purposes as a liquid biopsy. Furthermore, ex vivo modified or synthesized EVs can be engineered as therapeutic nano-shuttles. Finally, we highlight areas that merit further investigation relevant to understanding how EVs regulate liver disease pathogenesis. (Hepatology 2016;64:2219-2233).",
author = "Petra Hirsova and Ibrahim, {Samar C} and Verma, {Vikas K.} and Morton, {Leslie A.} and Vijay Shah and {La Russo}, {Nicholas F} and Gores, {Gregory James} and Malhi, {Harmeet M}",
year = "2016",
month = "12",
day = "1",
doi = "10.1002/hep.28814",
language = "English (US)",
volume = "64",
pages = "2219--2233",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Extracellular vesicles in liver pathobiology

T2 - Small particles with big impact

AU - Hirsova, Petra

AU - Ibrahim, Samar C

AU - Verma, Vikas K.

AU - Morton, Leslie A.

AU - Shah, Vijay

AU - La Russo, Nicholas F

AU - Gores, Gregory James

AU - Malhi, Harmeet M

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Extracellular vesicles (EVs) are nanometer-sized, membrane-bound vesicles released by cells into the extracellular milieu. EVs are now recognized to play a critical role in cell-to-cell communication. EVs contain important cargo in the form of proteins, lipids, and nucleic acids and serve as vectors for delivering this cargo from donor to acceptor or target cell. EVs are released under both physiologic and pathologic conditions, including liver diseases, and exert a wide range of effects on target cells. This review provides an overview on EV biogenesis, secretion, cargo, and target cell interactions in the context of select liver diseases. Specifically, the diverse roles of EVs in nonalcoholic steatohepatitis, alcoholic liver disease, viral hepatitis, cholangiopathies, and hepatobiliary malignancies are emphasized. Liver diseases often result in an increased release of EVs and/or in different cargo sorting into these EVs. Either of these alterations can drive disease pathogenesis. Given this fact, EVs represent a potential target for therapeutic intervention in liver disorders. Because altered EV composition may reflect the underlying disease condition, circulating EVs can be exploited for diagnostic and prognostic purposes as a liquid biopsy. Furthermore, ex vivo modified or synthesized EVs can be engineered as therapeutic nano-shuttles. Finally, we highlight areas that merit further investigation relevant to understanding how EVs regulate liver disease pathogenesis. (Hepatology 2016;64:2219-2233).

AB - Extracellular vesicles (EVs) are nanometer-sized, membrane-bound vesicles released by cells into the extracellular milieu. EVs are now recognized to play a critical role in cell-to-cell communication. EVs contain important cargo in the form of proteins, lipids, and nucleic acids and serve as vectors for delivering this cargo from donor to acceptor or target cell. EVs are released under both physiologic and pathologic conditions, including liver diseases, and exert a wide range of effects on target cells. This review provides an overview on EV biogenesis, secretion, cargo, and target cell interactions in the context of select liver diseases. Specifically, the diverse roles of EVs in nonalcoholic steatohepatitis, alcoholic liver disease, viral hepatitis, cholangiopathies, and hepatobiliary malignancies are emphasized. Liver diseases often result in an increased release of EVs and/or in different cargo sorting into these EVs. Either of these alterations can drive disease pathogenesis. Given this fact, EVs represent a potential target for therapeutic intervention in liver disorders. Because altered EV composition may reflect the underlying disease condition, circulating EVs can be exploited for diagnostic and prognostic purposes as a liquid biopsy. Furthermore, ex vivo modified or synthesized EVs can be engineered as therapeutic nano-shuttles. Finally, we highlight areas that merit further investigation relevant to understanding how EVs regulate liver disease pathogenesis. (Hepatology 2016;64:2219-2233).

UR - http://www.scopus.com/inward/record.url?scp=84995768489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995768489&partnerID=8YFLogxK

U2 - 10.1002/hep.28814

DO - 10.1002/hep.28814

M3 - Review article

C2 - 27628960

AN - SCOPUS:84995768489

VL - 64

SP - 2219

EP - 2233

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -